Complete Bibliography

Visit PubMed to view Dr. Neelendu Dey's complete publications record.

Selected Publications

Koester, S.T., Li, N., Lachance, D.M., and Dey, N. (2021). Marker-based assays for studying gut transit in gnotobiotic and conventional mouse models. STAR Protocols 2, 100938.

Li, N., Koester, S.T., Lachance, D.M., Dutta, M., Cui, J.Y., and Dey, N. (2021). Microbiome-encoded bile acid metabolism modulates colonic transit times. iScience 24, 102508.

Koester ST, Li N, Lachance DM, Morella NM, and Dey N. Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome. PLoS ONE. 16:e0248730, 2021. 

Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke C, Shaukat A, Rabeneck L, Ladabaum U, Bresalier R, Spiegel B, Yee J, Wang T, Lieberman D, Komanduri S, Muthusamy VR, Dey N. AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clinical Gastroenterology and Hepatology. 2020 Jul 4. 

Li S, Simoni Y, Becht E, Loh CY, Li N, Lachance D, Koo SL, Lim TP, Tan EKW, Mathew R, Nguyen A, Golovato J, Berkson JD, Prlic M, Lee B, Minot SS, Nagarajan N, Dey N, Tan DSW, Newell EW. Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer. Cell Reports Medicine. 2020 Jun;1(3):100039. 

Dey N, Kochman ML, Komanduri S, Melson JE, Muthusamy VR. Report from the AGA Center for GI Innovation and Technology’s Consensus Conference: Envisioning Next-Generation Paradigms in Colorectal Cancer Screening and Surveillance. Gastroenterology. 2019 Sep 13. 

Wagner VE*Dey N* (*co-first authors), Guruge J, Hsiao A, Ahern PP, Semenkovich NP, Blanton LV, Cheng J, Griffin N, Stappenbeck TS, Ilkayeva O, Newgard CB, Petri W, Haque R, Ahmed T, and Gordon JI.  Dissecting effects of community context on a gut pathobiont in a model of childhood undernutrition.  Science Translational Medicine 8(366):366ra164, 2016.

Vivio E, Kanuri N, Monroe K, Gilbertsen J, Dey N, Chen CH, Gutierrez AM, and Ciorba MA. Vedolizumab efficacy in IBD and safety over its first year in clinical practice. Journal of Crohn’s and Colitis 10(4):402-409, 2016.

Dey N, Wagner VE, Blanton LV, Cheng J, Fontana L, Haque R, Ahmed T, and Gordon JI. Regulators of Gut Motility Revealed 
by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel. Cell 163(1):95-107, 2015.

Dey N, Soergel D, Repo S, and Brenner SE. Association of gut microbiota with post-operative clinical course in Crohn’s disease. BMC Gastroenterology 13:131, 2013.

Soergel D, Dey N, Knight R, and Brenner SE. Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME Journal 6:1440-1444, 2012.